Literature DB >> 28573495

RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.

Lochlan J Fennell1, Mark Clendenning2, Diane M McKeone1, Saara H Jamieson1, Samanthy Balachandran1, Jennifer Borowsky1,3,4, John Liu1,3, Futoshi Kawamata1, Catherine E Bond1, Christophe Rosty2,4,5, Matthew E Burge6, Daniel D Buchanan2,4,7, Barbara A Leggett1,3,6, Vicki L J Whitehall8,9,10.   

Abstract

The WNT signaling pathway is commonly altered during colorectal cancer development. The E3 ubiquitin ligase, RNF43, negatively regulates the WNT signal through increased ubiquitination and subsequent degradation of the Frizzled receptor. RNF43 has recently been reported to harbor frequent truncating frameshift mutations in sporadic microsatellite unstable (MSI) colorectal cancers. This study assesses the relative frequency of RNF43 mutations in hereditary colorectal cancers arising in the setting of Lynch syndrome. The entire coding region of RNF43 was Sanger sequenced in 24 colorectal cancers from 23 patients who either (i) carried a germline mutation in one of the DNA mismatch repair genes (MLH1, MSH6, MSH2, PMS2), or (ii) showed immunohistochemical loss of expression of one or more of the DNA mismatch repair proteins, was BRAF wild type at V600E, were under 60 years of age at diagnosis, and demonstrated no promoter region methylation for MLH1 in tumor DNA. A validation cohort of 44 colorectal cancers from mismatch repair germline mutation carriers from the Australasian Colorectal Cancer Family Registry (ACCFR) were sequenced for the most common truncating mutation hotspots (X117 and X659). RNF43 mutations were found in 9 of 24 (37.5%) Lynch syndrome colorectal cancers. The majority of mutations were frameshift deletions in the G659 G7 repeat tract (29%); 2 cancers (2/24, 8%) from the one patient harbored frameshift mutations at codon R117 (C6 repeat tract) within exon 3. In the ACCFR validation cohort, RNF43 hotspot mutations were identified in 19/44 (43.2%) of samples, which was not significantly different to the initial series. The proportion of mutant RNF43 in Lynch syndrome related colorectal cancers is significantly lower than the previously reported mutation rate found in sporadic MSI colorectal cancers. These findings identify further genetic differences between sporadic and hereditary colorectal cancers. This may be because Lynch Syndrome cancers commonly arise in colorectal adenomas already bearing the APC mutation, whereas sporadic microsatellite unstable colorectal cancers arise from serrated polyps typically lacking APC mutation, decreasing the selection pressure on other WNT signaling related loci in Lynch syndrome.

Entities:  

Keywords:  Colorectal cancer; HNPCC; Lynch syndrome; MSI; Microsatellite instability; RNF43

Mesh:

Substances:

Year:  2018        PMID: 28573495      PMCID: PMC6086823          DOI: 10.1007/s10689-017-0003-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  20 in total

1.  Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells.

Authors:  Jun Yang; Wen Zhang; Paul M Evans; Xi Chen; Xi He; Chunming Liu
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers.

Authors:  Yun Sol Jo; Min Sung Kim; Ju Hwa Lee; Sug Hyung Lee; Chang Hyeok An; Nam Jin Yoo
Journal:  Hum Pathol       Date:  2015-07-15       Impact factor: 3.466

4.  RNF43 is frequently mutated in colorectal and endometrial cancers.

Authors:  Marios Giannakis; Eran Hodis; Xinmeng Jasmine Mu; Mai Yamauchi; Joseph Rosenbluh; Kristian Cibulskis; Gordon Saksena; Michael S Lawrence; Zhi Rong Qian; Reiko Nishihara; Eliezer M Van Allen; William C Hahn; Stacey B Gabriel; Eric S Lander; Gad Getz; Shuji Ogino; Charles S Fuchs; Levi A Garraway
Journal:  Nat Genet       Date:  2014-10-26       Impact factor: 38.330

5.  Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.

Authors:  J Young; L A Simms; K G Biden; C Wynter; V Whitehall; R Karamatic; J George; J Goldblatt; I Walpole; S A Robin; M M Borten; R Stitz; J Searle; D McKeone; L Fraser; D R Purdie; K Podger; R Price; R Buttenshaw; M D Walsh; M Barker; B A Leggett; J R Jass
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome.

Authors:  Aysel Ahadova; Magnus von Knebel Doeberitz; Hendrik Bläker; Matthias Kloor
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

7.  Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia.

Authors:  Bon-Kyoung Koo; Johan H van Es; Maaike van den Born; Hans Clevers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-28       Impact factor: 11.205

8.  Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.

Authors:  Swati Biswas; Patricia Trobridge; Judith Romero-Gallo; Dean Billheimer; Lois L Myeroff; James K V Willson; Sanford D Markowitz; William M Grady
Journal:  Genes Chromosomes Cancer       Date:  2008-02       Impact factor: 5.006

Review 9.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

10.  RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.

Authors:  Catherine E Bond; Diane M McKeone; Murugan Kalimutho; Mark L Bettington; Sally-Ann Pearson; Troy D Dumenil; Leesa F Wockner; Matthew Burge; Barbara A Leggett; Vicki L J Whitehall
Journal:  Oncotarget       Date:  2016-10-25
View more
  6 in total

1.  Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.

Authors:  Andreas Seeber; Francesca Battaglin; Kai Zimmer; Florian Kocher; Yasmine Baca; Joanne Xiu; Gilbert Spizzo; Veronica Novotny-Diermayr; Dietmar Rieder; Alberto Puccini; Jeff Swensen; Michelle Ellis; Richard M Goldberg; Axel Grothey; Anthony F Shields; John L Marshall; Benjamin A Weinberg; Paul E Sackstein; Kiat Hon Lim; Gek San Tan; Chadi Nabhan; W Michael Korn; Arno Amann; Zlatko Trajanoski; Martin D Berger; Emil Lou; Dominik Wolf; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2022-05-02       Impact factor: 13.801

Review 2.  Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries.

Authors:  Erbao Chen; Xiaojing Xu; Tianshu Liu
Journal:  J Oncol       Date:  2018-04-23       Impact factor: 4.375

3.  APC Mutation Marks an Aggressive Subtype of BRAF Mutant Colorectal Cancers.

Authors:  Lochlan J Fennell; Alexandra Kane; Cheng Liu; Diane McKeone; Winnie Fernando; Chang Su; Catherine Bond; Saara Jamieson; Troy Dumenil; Ann-Marie Patch; Stephen H Kazakoff; John V Pearson; Nicola Waddell; Barbara Leggett; Vicki L J Whitehall
Journal:  Cancers (Basel)       Date:  2020-05-06       Impact factor: 6.639

Review 4.  Molecular Features of the Serrated Pathway to Colorectal Cancer: Current Knowledge and Future Directions.

Authors:  Carla Satorres; María García-Campos; Marco Bustamante-Balén
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

5.  Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer.

Authors:  Abdul Khalid Siraj; Rong Bu; Tariq Masoodi; Sandeep Kumar Parvathareddy; Kaleem Iqbal; Wael Al-Haqawi; Hassan Al-Dossari; Saud Azam; Zeeshan Qadri; Padmanaban Annaiyappanaidu; Fouad Al-Dayel; Khawla Sami Al-Kuraya
Journal:  Sci Rep       Date:  2022-07-30       Impact factor: 4.996

6.  RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.

Authors:  Yasmijn J van Herwaarden; Lieke M Koggel; Femke Simmer; Elisa M Vink-Börger; Polat Dura; Gerrit A Meijer; Fokko M Nagengast; Nicoline Hoogerbrugge; Tanya M Bisseling; Iris D Nagtegaal
Journal:  Histopathology       Date:  2020-12-25       Impact factor: 5.087

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.